66 related articles for article (PubMed ID: 15719054)
1. Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma.
Azzedine H; Bolino A; Taïeb T; Birouk N; Di Duca M; Bouhouche A; Benamou S; Mrabet A; Hammadouche T; Chkili T; Gouider R; Ravazzolo R; Brice A; Laporte J; LeGuern E
Am J Hum Genet; 2003 May; 72(5):1141-53. PubMed ID: 12687498
[TBL] [Abstract][Full Text] [Related]
2. The causes of Charcot-Marie-Tooth disease.
Young P; Suter U
Cell Mol Life Sci; 2003 Dec; 60(12):2547-60. PubMed ID: 14685682
[TBL] [Abstract][Full Text] [Related]
3. Phosphoinositides and Charcot-Marie-tooth disease: new keys to old questions.
Suter U
Cell Mol Life Sci; 2007 Dec; 64(24):3261-5. PubMed ID: 17965826
[TBL] [Abstract][Full Text] [Related]
4. Highlighting the past and future of inherited peripheral neuropathies.
Zuchner S
J Neurol Neurosurg Psychiatry; 2024 May; ():. PubMed ID: 38744461
[No Abstract] [Full Text] [Related]
5. Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.
Houlden H; Reilly MM
Neuromolecular Med; 2006; 8(1-2):43-62. PubMed ID: 16775366
[TBL] [Abstract][Full Text] [Related]
6. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
7. Charcot-Marie-Tooth disease in Cyprus: epidemiological, clinical and genetic characteristics.
Nicolaou P; Zamba-Papanicolaou E; Koutsou P; Kleopa KA; Georghiou A; Hadjigeorgiou G; Papadimitriou A; Kyriakides T; Christodoulou K
Neuroepidemiology; 2010; 35(3):171-7. PubMed ID: 20571287
[TBL] [Abstract][Full Text] [Related]
8. [Molecular genetics of Charcot-Marie-Tooth disease].
Zhang YZ; Zhong N
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 37(1):100-5. PubMed ID: 15719054
[TBL] [Abstract][Full Text] [Related]
9. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
Niemann A; Berger P; Suter U
Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
[TBL] [Abstract][Full Text] [Related]
10. Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease.
Young P; Suter U
Brain Res Brain Res Rev; 2001 Oct; 36(2-3):213-21. PubMed ID: 11690618
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
